MedPath

COMPARING THE EFFECT OF TWO DRUGS CARBETOCIN AND OXYTOCIN IN THE PREVENTION OF POSTPARTUM HEMORRHAGE IN PRIMIGRAVIDA

Not Applicable
Recruiting
Registration Number
CTRI/2023/04/051274
Lead Sponsor
SDM COLLEGE MEDICAL SCIENCE AND HOSPITA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

ALL PRIMIGRAVIDA WITH VAGINAL DELIVERY WITH NO COMBRIDITES

Exclusion Criteria

1.MULTIPLE PREGNANCIES

2.MULTIGRAVIDA

3.COAGULOPATHY,HEMATOLOGICAL DISORDERS

4.CASEAREAN SECTIO

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
TO DETERMINE THE EFFECTIVENESS OF UTEROTONIC (OXYTOCIN AND CARBETOCIN)WHICHHELPS IN REDUCING THE POSTPARTUM BLOOD LOSSTimepoint: 48 HRS AFTER THE DELIVERY BY COMPARING THE PRE HB AND POSTHB AND ESTIMATION OF BLOOD LOSS AFTER DELIVERY.
Secondary Outcome Measures
NameTimeMethod
TO ESTIMATE THE PROPORTION OF WOMEN RECEIVING EXTRAUTERTONIC DRUGS <br/ ><br>WOMEN REQUIRING TRANSFUSION OF BLOOD OR BLOOD PRODUCTS. <br/ ><br>EFFICACY OF THE DRUG IS MEASURED BY COMPARING THE BLOOD LOSS AND PREHB AND POST HB AFTER 48HRS AFTER DELIVERY FOR THE PREVENTION OF PPH SO THAT WE CAN DECREASE MATERNAL MORTALITY.Timepoint: COMPARING THE BLOOD LOSS AFTER THE THIRD STAGE OF LABOR AND 48HR AFTER THE DELIVERY COMPARING PRE HB AND POST HB
© Copyright 2025. All Rights Reserved by MedPath